findmyKOL

Gregory Downey, MD

Enriched profile

Executive Vice President of Academic Affairs and Provost, National Jewish Health · National Jewish Health

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Denver, CO · West · United StatesSpecialtyPulmonary DiseaseFocusNeutrophil, Myeloperoxidase and Oxidative Mechanisms+4
Active KOLfindmyKOL type: EliteLatest publication2023Online presenceverified 2026Payments2021–2025NIH funding1987–2026

Gregory Downey is Executive Vice President of Academic Affairs and Provost, National Jewish Health at National Jewish Health. OpenAlex indexes 334 publications with 21,561 citations (h-index 79); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.

Data verified 18 Oct 2026

Overview

Updated 18 Oct 2026

Gregory Downey, MD, is Executive Vice President of Academic Affairs and Provost, National Jewish Health. The public record shows 334 publications with 21,561 citations (h-index 79), centered on Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Respiratory Support and Mechanisms. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 5 companies, 8 NIH-funded awards (1987–2026).

  • Most recent indexed publication: 2023 · Annals of the American Thoracic Society
  • Top research focus: Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 5 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Idiopathic Pulmonary Fibrosis1 trial

Research focus

OpenAlex concept fingerprint
Neutrophil, Myeloperoxidase and Oxidative MechanismsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisRespiratory Support and MechanismsProtein Kinase Regulation and GTPase SignalingCell Adhesion Molecules Research

Drugs & molecules

across trials, industry payments and publications
Breztrigeneric · Budesonide / formoterol / glycopyrroniumClinical trials—Industry payments10Publications—Fasenrageneric · BenralizumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
AstraZeneca Pharmaceuticals LPClinical trials—Industry payments12Vertex Pharmaceuticals IncorporatedClinical trials—Industry payments2Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments1National Jewish HealthClinical trials1Industry payments—Olympus America Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
334publications

Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.

21,561citations

Total citations across indexed works.

79h-index

Hirsch index (OpenAlex). i10-index 195.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
5companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
8NIH grants · 1987–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    63.1%
    beta2-Adrenergic Agonist32.8%
    Albuterol Sulfate Hfa53%Ventolin Hfa48%
    Part D<11 patients
    Corticosteroid30.3%
    Arnuity Ellipta100%
    Part D<11 patients
  • Cancer & immunology

    18.9%
    Kinase inhibitor18.9%
    Ofev100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    18%
    Corticosteroid18%
    Prednisone100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

8 NIH research awards on record, funded 1987–2026 per NIH RePORTER. The latest:

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Sergio Grinstein33Yael Aschner29Christopher A. McCulloch28Rachel L. Zemans24Thomas K. Waddell18Chung‐Wai Chow17Theo J. Moraes16Kelly A. Correll16Léa Fialkow15Natalie J. Briones14Peter M. Henson14K.M. Beke14Hong Wei Chu13G. Scott Worthen13David W. H. Riches13Vera Cherepanov12Daniel G. Foster11Jonathan D. Plumb11Helen M. Roybal11Qin Wang11Arthur S. Slutsky10Brian J. Day10Katherine A. Siminovitch10Francis X. McCormack10Warren L. Lee9Elizabeth F. Redente9Hedy H. Ginzberg9Maria Teresa Herrera Abreu9Cecile Stephanie Rose9Tomoko Suzuki9Scott K. Young9Yoshikazu Inoue8Paul R. Reynolds8Dhaarmini Rajshankar8Cory M Yamashita8Lisa R. Young7Meghan Nelson7Irina Petrache7Kevin K. Brown7Eric P. Schmidt7

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/gregory-downey-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    cts-sct.ca/speaker/dr-gregory-downey-2

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cts-sct.ca ↗
  • Other

    nationaljewish.org/doctors-departments/gregory-p-downey

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nationaljewish.org ↗
  • Other

    thoracic.org/about/newsroom/press-releases/conference/leadership-for-2022-2023.php

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thoracic.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Interview

    Touch Medical Media, World Lung Day 2022, ATS President discussion

    2022
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →touchrespiratory.com ↗
  • Public Dialogue Speaker

    National Jewish Health Dialogue with a Doc event, February 4

    2022
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bocaratonobserver.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.